Serialization plays an essential role in maintaining supply chain integrity, discouraging counterfeiting, and meeting regulatory requirements. In the United States, manufacturers are preparing for the Nov. 27, 2023 aggregation deadline to meet requirements of the Drug Supply Chain Security Act (DSCSA). “Aggregation is the process of ensuring that each unique serialized item is associated to its packaging and that packaging also includes a unique serial number,” explains Marta Schaefer, pharma account specialist at Videojet Technologies.
To read more, follow the link to the source.
Source: https://www.pharmtech.com/view/moving-forward-in-serialization